Daolin Tang Selected Research

COVID-19

12/2020	Chloroquine in fighting COVID-19: good, bad, or both?
12/2020	HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
1/2020	The hallmarks of COVID-19 disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daolin Tang Research Topics

Disease

120	Neoplasms (Cancer) 05/2024 - 12/2008
32	Inflammation (Inflammations) 01/2022 - 03/2009
28	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2011
22	Carcinogenesis 03/2024 - 01/2010
21	Sepsis (Septicemia) 07/2022 - 05/2005
19	Adenocarcinoma 11/2023 - 06/2012
16	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2010
16	Necrosis 01/2023 - 03/2009
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2015
15	Infections 01/2022 - 03/2007
11	Leukemia 12/2023 - 01/2011
10	Bites and Stings (Sting) 12/2023 - 10/2017
8	Pancreatitis 01/2023 - 04/2014
8	Endotoxemia 07/2022 - 12/2009
6	Ischemia 10/2023 - 01/2011
6	Starvation 01/2023 - 09/2010
6	Hypoxia (Hypoxemia) 01/2021 - 07/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 10/2015
5	Rupture 05/2024 - 01/2020
5	Reperfusion Injury 03/2024 - 10/2014
5	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 05/2012
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 09/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 12/2014
4	Iron Overload 01/2023 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2021
3	Pathologic Processes 11/2022 - 10/2014
3	Melanoma (Melanoma, Malignant) 01/2021 - 07/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2018
3	COVID-19 12/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

56	HMGB1 Protein (HMG1)IBA 01/2024 - 05/2005
44	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2008
20	IronIBA 05/2024 - 01/2016
11	UbiquitinIBA 10/2023 - 11/2015
10	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2023 - 11/2015
10	CytokinesIBA 01/2021 - 06/2007
9	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 04/2011
9	AntioxidantsIBA 01/2023 - 04/2011
9	InterferonsIBA 01/2022 - 03/2013
9	erastinIBA 11/2021 - 10/2015
9	InflammasomesIBA 01/2021 - 07/2014
9	Receptor for Advanced Glycation End ProductsIBA 01/2019 - 03/2009
8	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 11/2023 - 01/2021
7	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2015
6	Chloroquine (Aralen)FDA LinkGeneric 03/2024 - 01/2012
6	Messenger RNA (mRNA)IBA 12/2022 - 09/2011
6	Small Interfering RNA (siRNA)IBA 11/2022 - 04/2013
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024 - 01/2021
5	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2016
5	Ferritins (Ferritin)IBA 01/2023 - 01/2016
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 07/2015
5	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 02/2013
5	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 01/2016
5	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 12/2020
5	MicroRNAs (MicroRNA)IBA 11/2021 - 05/2012
5	Long Noncoding RNAIBA 11/2021 - 12/2017
5	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 06/2007
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2012
4	CopperIBA 03/2024 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2013
4	BilirubinIBA 11/2023 - 01/2021
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2007
4	Phosphotransferases (Kinase)IBA 01/2023 - 01/2020
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 03/2009
4	Endosomal Sorting Complexes Required for TransportIBA 01/2023 - 01/2020
4	Histones (Histone)IBA 01/2021 - 09/2016
4	ChemokinesIBA 01/2021 - 05/2015
4	Arginine (L-Arginine)FDA Link 12/2020 - 04/2014
4	AlarminsIBA 01/2019 - 01/2011
4	EndotoxinsIBA 10/2018 - 03/2007
3	Malondialdehyde (Propanedial)IBA 03/2024 - 01/2021
3	Glutathione (Reduced Glutathione)IBA 03/2024 - 01/2021
3	LigandsIBA 12/2023 - 03/2009
3	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2022
3	Carrier Proteins (Binding Protein)IBA 11/2023 - 01/2023
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2023 - 01/2019
3	Phospholipids (Phosphatides)FDA LinkGeneric 10/2023 - 12/2022
3	adagrasibIBA 01/2023 - 10/2021
3	Beclin-1IBA 01/2023 - 01/2012
3	Pattern Recognition ReceptorsIBA 01/2023 - 10/2014
3	AMP-Activated Protein KinasesIBA 01/2023 - 01/2018
3	sotorasibIBA 01/2023 - 10/2021
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 10/2017
3	Ubiquitin-Specific ProteasesIBA 01/2023 - 01/2018
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2023 - 04/2011
3	InterleukinsIBA 01/2023 - 07/2014
3	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2023 - 01/2016
3	N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA 01/2023 - 01/2018
3	NF-kappa B (NF-kB)IBA 01/2023 - 10/2011
3	Deubiquitinating EnzymesIBA 11/2022 - 01/2018
3	CeruletideIBA 01/2022 - 04/2014
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 07/2015
3	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2012
3	EnzymesIBA 12/2020 - 07/2014

Therapy/Procedure

58	Therapeutics 05/2024 - 12/2009
24	Drug Therapy (Chemotherapy) 05/2024 - 01/2011
9	Immunotherapy 05/2024 - 01/2013
6	Radiotherapy 05/2024 - 01/2020
3	Ligation 12/2020 - 09/2016
3	Punctures 12/2020 - 09/2016